COVID-19 / Coronavirus

AnPac Bio-Medical Science Enters into Definitive Agreement to Acquire Fresh2 Ecommerce Inc, a B2B Asian Food E-commerce Platform

2023-02-09 21:00 2977

Transaction expected to fuel the Company's growth in the U.S. food market NEW YORK, Feb. 9, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ: ANPC), a company with operations inthe United States andChina focused on early cancer screening and detection and plans to ...

GC Biopharma Receives WHO Pre-Qualification for Filling and Finish Plant in Ochang, South Korea

2023-02-09 09:21 1736

YONGIN, South Korea, Feb. 8, 2023 /PRNewswire/ -- GC Biopharma (006280.KS), a leading provider of biopharmaceutical products inSouth Korea, announced today that the World Health Organization (WHO) has awarded prequalification to filling and finish plant onFebruary 3 2023, located in Ochang, South...

U.S. Centers for Disease Control to extend National Wastewater Surveillance System contract with Biobot Analytics

2023-02-09 06:15 2315

CAMBRIDGE, Mass., Feb. 9, 2023 /PRNewswire/ -- The U.S. Centers for Disease Control and Prevention (CDC) has extended its partnership with Biobot Analytics through the National Wastewater Surveillance System (NWSS) to bring COVID-19 and mpox (formerly monkeypox) wastewater analysis to communities...

SUMMIT HEALTHCARE ACQUISITION CORP. AND YS BIOPHARMA ANNOUNCE EFFECTIVENESS OF REGISTRATION STATEMENT AND EXTRAORDINARY GENERAL MEETING DATE FOR PROPOSED BUSINESS COMBINATION

2023-02-08 21:30 2960

* Extraordinary general meeting of Summit Healthcare Acquisition Corp.'s shareholders to be held onMarch 1, 2023 at 9:00 a.m. Eastern Time * YS Biopharma is a global biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines a...

SUMMIT HEALTHCARE ACQUISITION CORP. AND YS BIOPHARMA ANNOUNCE EFFECTIVENESS OF REGISTRATION STATEMENT AND EXTRAORDINARY GENERAL MEETING DATE FOR PROPOSED BUSINESS COMBINATION

2023-02-08 21:30 3066

* Extraordinary general meeting of Summit Healthcare Acquisition Corp.'s shareholders to be held onMarch 1, 2023 at 9:00 a.m. Eastern Time * YS Biopharma is a global biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines a...

Zhongchao Inc. Announces the Application of ChatGPT to Elevate Patient Management Service Capabilities and Experience

2023-02-08 20:30 1745

SHANGHAI, Feb. 8, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with oncology and other major diseases, today announced the application of ChatGPT (Chat Generative Pre-trained Transform...

RNAimmune mRNA Cancer Vaccine Program Accepted for Oral Presentation at the 2023 AACR Annual Meeting

2023-02-07 16:34 2665

HONG KONG, GERMANTOWN, Md., and SUZHOU, China, Feb. 7, 2023 /PRNewswire/ --  Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, and together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company in discovery and development of RNAi therapeutics today announced ...

Qurient Co. Ltd. and TB Alliance Announce Exclusive License Agreement for Telacebec (Q203), a New Anti-Tuberculosis Agent

2023-02-03 14:34 2488

Landmark Agreement for New Tuberculosis Treatment SEONGNAM-SI, South Korea and NEW YORK, Feb. 3, 2023 /PRNewswire/ -- Qurient Co. Ltd. ("Qurient", KRX: 115180), a clinical-stage biotechnology company based inSouth Korea, and TB Alliance, a not-for-profit organization dedicated to the discovery, ...

TotalEnergies ENEOS Signs Solar Rooftop Project with Ecolite, a health and wellness company in Malaysia

2023-02-02 10:00 10120

KUALA LUMPUR, Malaysia, Feb. 2, 2023 /PRNewswire/ -- Ecolite Biotech Manufacturing Sdn Bhd, a health and wellness company inMalaysia, has signed a long-term agreement with TotalEnergies ENEOS to provide a 0.4 megawatt-peak (MWp) solar photovoltaic (PV) system to its facility inMalaysia. Ecolite i...

Global Times: Small and mid-sized cities in China go through infection peak, bearing new hope for future

2023-02-01 22:45 2108

BEIJING, Feb. 1, 2023 /PRNewswire/ -- As media sources around the world have paid so much attention to infection surges in various metropolises or first-and-second-tier cities inChina and governments at all levels have attached great importance to anti-epidemic work in rural areas, a review on ho...

THE FARRER PARK COMPANY APPOINTS NEW GROUP CHIEF OPERATING OFFICER AND ACTING GROUP CHIEF EXECUTIVE OFFICER

2023-02-01 09:15 3203

SINGAPORE, Feb. 1, 2023 /PRNewswire/ -- The Farrer Park Company Pte Ltd (TFPC) announced today the appointment of Ms.Kelly Yang as its Group Chief Operating Officer and Acting Group Chief Executive Officer. Ms. Yang brings to TFPC 23 years of healthcare experience. She was most recently the Chie...

Global Times: Having weathered epidemic storms overseas, Chinese return to hometown for safe, joyous Spring Festival reunions

2023-01-31 22:10 2139

BEIJING, Jan. 31, 2023 /PRNewswire/ -- Red lanterns are once again hung in the contemporary houses that combine Chinese and Western elements in the famous hometown of overseas Chinese in East China'sFujian Province. For countless overseas Chinese, this year's Spring Festival provided an opportun...

Global Times: 'So much better than we had anticipated': China's rural regions embrace Spring Festival as COVID peak ebbs away

2023-01-31 21:41 2105

BEIJING, Jan. 31, 2023 /PRNewswire/ -- The Spring Festival is rooted in agricultural civilization. Chinese people believe the most traditional atmosphere of Spring Festival is in rural regions. Since the prevention and control of the COVID-19 epidemic has entered a new stage, questions have been...

Innovation Deficit: Funds for Neglected Diseases like TB are Falling Short

2023-01-31 21:30 1778

NEW YORK, Jan. 31, 2023 /PRNewswire/ -- The 2022 G-FINDER Report, released today, reveals that for the year 2021, global funding for the development of critical new health technologies to overcome the world's deadliest neglected diseases remained woefully inadequate and largely stagnant. Specific...

Zhongchao Inc. Announces Introduction of Indian Anti-influenza Drugs to China

2023-01-31 20:30 1642

SHANGHAI, Jan. 31, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with oncology and other major diseases, today announced that that Chongqing Xinjiang Pharmaceutical Co., Ltd. ("Xinjiang...

AXA Designated Endoscopy and Day Surgery Centre officially unveils

2023-01-31 18:30 2682

* Partnering with EC Healthcare to create one-stop services providing health check-ups, medical examinations and treatments * No pre-authorisation required for designated endoscopy and day surgery HONG KONG, Jan. 31, 2023 /PRNewswire/ -- AXA Hong Kong and Macau ("AXA") announced the official ...

Ascletis Announces U.S. FDA Approval of Conducting a Phase IIa Clinical Trial for ASC10 to Treat Respiratory Syncytial Virus Infection

2023-01-31 17:40 2567

--Respiratory syncytial virus (RSV) infection treatment remains huge unmet medical needs and there is no effective drug for treatment globally so far --Dosage of 800 mg ASC10, twice daily was selected to conduct a Phase IIa study in patients with RSV infection --Preclinical research showed t...

Delivery of 170,000 Bottles of Azvudine Tablets During Spring Festival to Help Rural Areas Weather the Epidemic

2023-01-31 16:10 3157

HONG KONG, Jan. 31, 2023 /PRNewswire/ -- In response to the infection peak season of COVID-19 in rural areas that may be brought about by people returning home during Chinese New Year, Fosun Foundation announced on9 January 2023 the cooperation with Fosun Pharma and Genuine Biotech to donateRMB10...

PM-International donates €1,872,000 to charity sponsoring 5,200 children around the world

2023-01-31 10:00 1944

SCHENGEN, Luxembourg, Jan. 31, 2023 /PRNewswire/ -- PM-International is thrilled to announce that its charity arm known as "PM We Care" is pushing the boundaries for 2023 by donating €1,872,000, the most it has ever given, to support the health, education and a good environment for thousands of c...

Novotech Awarded by Frost & Sullivan for Global Biotech Clinical Trials Excellence in APAC

2023-01-31 05:37 1984

With a proven biotech market leadership position, Novotech's compelling value proposition drives its sustained success in delivering biotech clinical trials. SAN ANTONIO, Jan. 31, 2023 /PRNewswire/ -- Frost & Sullivan recently analyzed theAsia-Pacific contract research organization industry and, ...

1 ... 16171819202122 ... 226